BioCorRx Provides Business Update for 2022

3 years ago

Revenue Increases 343% for 2022 Due to Increased Number of Patients Treated at Licensed Clinics ANAHEIM, CA, April 03, 2023…

GeneDx Appoints Devin K. Schaffer, J.D., M.B.A, as General Counsel

3 years ago

Devin K. Schaffer, J.D., M.B.A, General Counsel, GeneDx GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic…

Vaccinex Announces Private Placement with Commitments of $5.0 Million

3 years ago

ROCHESTER, N.Y., April 03, 2023 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX) (“Vaccinex” or the “Company”), a clinical-stage biotechnology company…

Palisade Bio Announces $6 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under Nasdaq Rules

3 years ago

Carlsbad, CA, April 03, 2023 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI), a biopharmaceutical company advancing therapies for acute and chronic…

Assure Holdings Reports 2022 Year End Financial Results

3 years ago

DENVER, April 03, 2023 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative…

A Novel Immunotherapeutic Approach to Treating Aging-Associated Diseases

3 years ago

HCW Biologics Published a Pivotal Scientific Paper in Aging Cell Subcutaneous Administration of HCW9218 Systemically Reduces Senescent Cells and Alleviates Senescence-Associated…

Integra LifeSciences to Host First Quarter 2023 Financial Results Conference Call on April 26, 2023

3 years ago

PRINCETON, N.J., April 03, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will…

PDS Biotech Supports Oral, Head & Neck Cancer Awareness Month During April and Oral, Head & Neck Cancer Awareness Week from April 16-22, 2023

3 years ago

PDS Biotech prepares to advance PDS0101 into a Phase 3 registrational clinical trial – VERSATILE-003 – in HPV16-positive recurrent and/or…

NewAmsterdam Pharma Appoints Janneke van der Kamp to its Board of Directors

3 years ago

NAARDEN, the Netherlands and MIAMI, April 03, 2023 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam Pharma”…

Alimera Announces Expansion of Agreement with Distribution Partner Horus Pharma to Include Marketing ILUVIEN® in the Nordic Countries

3 years ago

Horus to increase ILUVIEN commercial presence with Nordic Retinal SpecialistsATLANTA, April 03, 2023 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq:…